Besivance
Active substance: Besifloxacin
SUSPENSION · BESIFLOXACIN 6 mg/mL
United StatesActive
Marketing holder: Bausch & Lomb Incorporated
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BESIFLOXACIN · 6 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12093-4af8-775b-83a6-cf9945d1da8c,01a12097-bdfb-7507-bf1f-8769d5d21c5c,01a1209a-2c17-709e-8c0f-6cfeaf59f5b6,01a1209c-a489-7323-b98b-3535085e6436;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 24208-446
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- OPHTHALMIC
Sources
- product · openFDA NDC · 24208-446 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24208-446 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24208-446 · Verified 2026-10-09 · open in source